Filing Details

Accession Number:
0001415889-22-008894
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-08-19 15:45:10
Reporting Period:
2022-08-17
Accepted Time:
2022-08-19 15:45:10
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1411685 Vistagen Therapeutics Inc. VTGN Pharmaceutical Preparations (2834) 205093315
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1924908 G. Reid Adler C/O Vistagen Therapeutics, Inc.
343 Allerton Avenue
South San Francisco CA 94080
Chief Legal Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-08-17 300,000 $0.17 334,629 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.1689 to $0.1701, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4.